Literature DB >> 10856516

Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery.

G Pasterkamp1, A H Schoneveld, D J Hijnen, D P de Kleijn, H Teepen, A C van der Wal, C Borst.   

Abstract

Atherosclerotic luminal narrowing is determined by plaque mass and the mode of geometrical remodeling. Recently, we reported that the type of atherosclerotic remodeling is associated with the presence of histological markers for plaque vulnerability. Inflammation and matrix degrading proteases (MMPs) may play a role in both plaque vulnerability and in expansive arterial remodeling. The aim of the present study was to investigate the association between the remodeling mode and the localization of macrophages and MMPs in coronary atherosclerotic segments. From 36 atherosclerotic coronary arteries, 45 and 51 segments were selected with a vessel area that was >10% smaller and larger compared with the adjacent segments, respectively. No significant difference in staining for macrophages was observed between segments with expansive and constrictive remodeling. More MMP-2 and MMP-9 staining was observed in plaques of expansively remodeled segments compared with constrictively remodeled segments. In general, MMP-staining was less evident in the adventitial layer compared with the plaque. Zymography revealed more active MMP-2 in expansively remodeled segments compared with constrictively remodeled segments (340+/-319 vs. 199+/-181 (adjusted counts/mm(2)), respectively, P=0.019). Zymography did not show differences in inactive MMP-2 or MMP-9 among groups. It might be postulated that MMPs within the plaque play a causal role not only in plaque vulnerability but also in de novo atherosclerotic remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856516     DOI: 10.1016/s0021-9150(99)00371-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  51 in total

1.  Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini.

Authors:  Ivano Eberini; Laura Calabresi; Robin Wait; Gabriella Tedeschi; Angela Pirillo; Lina Puglisi; Cesare R Sirtori; Elisabetta Gianazza
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

2.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

3.  Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems.

Authors:  Yoshiki Matsuo; Takuro Takumi; Verghese Mathew; Woo-Young Chung; Gregory W Barsness; Charanjit S Rihal; Rajiv Gulati; Eric T McCue; David R Holmes; Eric Eeckhout; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2012-05-31       Impact factor: 5.162

4.  In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography.

Authors:  Owen Christopher Raffel; Faisal M Merchant; Guillermo J Tearney; Stanley Chia; Denise Dejoseph Gauthier; Eugene Pomerantsev; Kyoichi Mizuno; Brett E Bouma; Ik-Kyung Jang
Journal:  Eur Heart J       Date:  2008-06-24       Impact factor: 29.983

5.  Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population.

Authors:  Ivan Delgado-Enciso; Nelida A Gonzalez-Hernandez; Luz M Baltazar-Rodriguez; Rebeca O Millan-Guerrero; Oscar Newton-Sanchez; Alfonso Bayardo-Noriega; Alfonso Aleman-Mireles; Irma G Enriquez-Maldonado; Ma J Anaya-Carrillo; Augusto Rojas-Martinez; Rocio Ortiz-Lopez
Journal:  J Genet       Date:  2009-08       Impact factor: 1.166

6.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 7.  Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approaches.

Authors:  G Dimas; F Iliadis; D Grekas
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

Review 8.  Metalloproteinases and plasminogen activators in vessel remodeling.

Authors:  Alex Bobik; Vselovod Tkachuk
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

9.  A robust rabbit model of human atherosclerosis and atherothrombosis.

Authors:  Alkystis Phinikaridou; Kevin J Hallock; Ye Qiao; James A Hamilton
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

10.  Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells.

Authors:  Sang-Hee Kwon; Seong-A Ju; Ji-Hye Kang; Chu-Sook Kim; Hyeon-Mi Yoo; Rina Yu
Journal:  Nutr Res Pract       Date:  2008-06-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.